Viewing Study NCT00433433


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2025-12-29 @ 5:46 AM
Study NCT ID: NCT00433433
Status: UNKNOWN
Last Update Posted: 2021-02-03
First Post: 2007-02-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: EORTC-20051
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View